Skip to main navigation Skip to search Skip to main content

Cell type-specific methylome-wide association studies of childhood ADHD symptoms

  • Mandy Meijer
  • , Marieke Klein*
  • , Doretta Caramaschi
  • , Shaunna L. Clark
  • , Marta Cosin-Tomas
  • , Nastassja Koen
  • , Xueling Lu
  • , Rosa H. Mulder
  • , Stefan W. Röder
  • , Yining Zhang
  • , Lea Zilich
  • , Mariona Bustamente
  • , Michael Deuschle
  • , Janine F. Felix
  • , Juan Ramos González
  • , Regina Gražulevičiene
  • , Fabian Streit
  • , John Wright
  • , Angel Carracedo
  • , Charlotte A.M. Cecil
  • Eva Corpeleijn, Catharina A. Hartman, Gunda Herberth, Anke Huels, Caroline Relton, Harold Snieder, Dan J. Stein, Jordi Sunyer, Stephanie H. Witt, Heather J. Zar, Ana C. Zenclussen, Barbara Franke, William Copeland, Karolina A. Aberg, Edwin J.C.G. van den Oord
*Corresponding author for this work
  • Donders Institute for Brain, Cognition and Behaviour
  • Radboud University Medical Center
  • University of Exeter
  • Texas A&M University
  • Pompeu Fabra University
  • University of Cape Town
  • University Medical Centre Groningen
  • Helmholtz Centre for Environmental Research
  • Emory University
  • Heidelberg University 
  • Vytautas Magnus University
  • Bradford Institute for Health Research
  • Instituto de Investigación Sanitaria de Santiago de Compostela
  • University of Bristol
  • University of Vermont College of Medicine
  • Virginia Commonwealth University

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
3 Downloads (Pure)

Abstract

Studying DNA methylation (DNAm) can provide insights into gene-regulatory mechanisms underlying attention-deficit/hyperactivity disorder (ADHD). While most DNAm studies were performed in bulk tissue, this study used statistical deconvolution to identify cell type-specific DNAm profiles, from five major blood cell types, associated with childhood ADHD symptoms. We performed meta-analyses of methylome-wide association studies (MWAS) for ADHD symptoms (agerange=4–16 years) in peripheral blood collected during childhood and in cord blood. The investigated cohorts included seven array-based methylation datasets assaying up to 450 K CpGs from the Pregnancy And Childhood Epigenetics Consortium (N=2 934 peripheral blood; N=2 546 cord blood) and a sequencing-based methylation dataset assaying nearly all 28 million CpGs in blood from the Great Smoky Mountain Study (GSMS; N=583). The meta-analyses resulted in methylome-wide significant (FDR<0.05) ADHD associations in CD8T cells ( RPL31P11 and KCNJ5) for peripheral blood, and, in cord blood, in monocytes ( PDE6B ), CD8T cells ( KCNA3 and HAND2 ), and NK cells ( KIFC1 ). Notably, several significant sites detected in peripheral blood ( RPL31P11 and KCNJ5 ) were also detected in cord blood. Furthermore, extended MWAS of all sites available for GSMS detected 69 and 17 additional CpGs in monocytes and granulocytes, respectively. In this first cell type-specific MWAS for ADHD, we identified DNAm associations for ADHD symptoms; some associations were seen in both peripheral blood and cord blood, suggesting potential susceptibility markers for increased ADHD risk. These findings show that cell type-specific analyses and sequencing-based approaches can increase insights into the epigenetic patterns associated with ADHD symptoms in childhood.

Original languageEnglish
Pages (from-to)7-17
Number of pages11
JournalEuropean Neuropsychopharmacology
Volume101
DOIs
Publication statusPublished - Dec 2025

Bibliographical note

Publisher Copyright:
Copyright © 2025. Published by Elsevier B.V.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Cell type-specific methylome-wide association studies of childhood ADHD symptoms'. Together they form a unique fingerprint.

Cite this